Wells Fargo & Company Xencor Inc Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Xencor Inc stock. As of the latest transaction made, Wells Fargo & Company holds 24,066 shares of XNCR stock, worth $468,565. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,066
Previous 19,575
22.94%
Holding current value
$468,565
Previous $433,000
5.08%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding XNCR
# of Institutions
203Shares Held
63.1MCall Options Held
3.9KPut Options Held
3K-
Black Rock Inc. New York, NY11.1MShares$216 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.12MShares$177 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$136 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$104 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$77.1 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.16B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...